.5ml semaglutide Rx Item-Wegovy 0.5Mg/.5Ml Inj 4X0.5 By Novo Nordisk USA Medical Weight Loss Programs |

1996 Nov 1;12(16):1537-41

GLP-1 receptor agonists are not typically associated with drug-induced liver injury and generally do not cause liver damage

Obesity is a disease, and medication can be part of legitimate treatment

Medicaid & Medi-Cal patients cannot use Midis services. This is a hard gate for those populations and is worth knowing before committing to the registration flow

Healthcare providers work closely with patients to establish a medical weight management plan that not only aids in losing weight but also focuses on maintaining it, thereby improving health outcomes across the board

The consistent signal is that both move a large majority of patients past clinically meaningful weight-loss thresholds